Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delta Synthetic (Fujian) Biotech Co., Ltd. is a specialized manufacturer of high-end pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), with a core focus on nucleoside and nucleotide chemistry. Based in Sanming, Fujian, China, the company provides contract development and manufacturing services (CDMO) for global pharmaceutical clients, particularly in the fields of antiviral and oncology therapeutics. Their product portfolio includes critical intermediates for major drugs such as Remdesivir and Molnupiravir. Delta Synthetic operates large-scale production facilities that adhere to international quality standards, supporting drug development from laboratory research to commercial-scale supply. The company is recognized for its technical expertise in complex multi-step organic synthesis and high-pressure hydrogenation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delta Synthetic.